Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Research Report 2024

Report ID: 1978240 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 CMX-020
        1.2.3 CA-016
        1.2.4 DD-04107
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Ophthalmology
        1.3.3 Immunology
        1.3.4 Muscle Spasm
        1.3.5 Pruritus
        1.3.6 Abdominal Pain
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2017-2028)
    2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
        2.2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Region (2017-2022)
        2.2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2023-2028)
    2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
        2.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
        2.3.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
        2.3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
        2.3.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue
        3.1.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (2017-2022)
        3.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2017-2022)
    3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue
    3.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio
        3.4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2021
    3.5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Area Served
    3.6 Key Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
    3.7 Date of Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Type
    4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Type (2017-2022)
    4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2023-2028)
5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Application
    5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2017-2022)
    5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2017-2028)
    6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
    6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2017-2028)
    7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
    7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2017-2028)
    8.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
    8.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2017-2028)
    9.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
    9.3 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2017-2028)
    10.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
    10.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen Inc
        11.1.1 Amgen Inc Company Detail
        11.1.2 Amgen Inc Business Overview
        11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.1.4 Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.1.5 Amgen Inc Recent Development
    11.2 Amorepacific Corp
        11.2.1 Amorepacific Corp Company Detail
        11.2.2 Amorepacific Corp Business Overview
        11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.2.4 Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.2.5 Amorepacific Corp Recent Development
    11.3 BCN Peptides SA
        11.3.1 BCN Peptides SA Company Detail
        11.3.2 BCN Peptides SA Business Overview
        11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.3.4 BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.3.5 BCN Peptides SA Recent Development
    11.4 Centrexion Therapeutics Corp
        11.4.1 Centrexion Therapeutics Corp Company Detail
        11.4.2 Centrexion Therapeutics Corp Business Overview
        11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.4.4 Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.4.5 Centrexion Therapeutics Corp Recent Development
    11.5 Daewoong Pharmaceutical Co Ltd
        11.5.1 Daewoong Pharmaceutical Co Ltd Company Detail
        11.5.2 Daewoong Pharmaceutical Co Ltd Business Overview
        11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.5.4 Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.5.5 Daewoong Pharmaceutical Co Ltd Recent Development
    11.6 DoNatur GmbH
        11.6.1 DoNatur GmbH Company Detail
        11.6.2 DoNatur GmbH Business Overview
        11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.6.4 DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.6.5 DoNatur GmbH Recent Development
    11.7 Flex Pharma Inc
        11.7.1 Flex Pharma Inc Company Detail
        11.7.2 Flex Pharma Inc Business Overview
        11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.7.4 Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.7.5 Flex Pharma Inc Recent Development
    11.8 Grunenthal GmbH
        11.8.1 Grunenthal GmbH Company Detail
        11.8.2 Grunenthal GmbH Business Overview
        11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.8.4 Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.8.5 Grunenthal GmbH Recent Development
    11.9 Kyowa Hakko Kirin Co Ltd
        11.9.1 Kyowa Hakko Kirin Co Ltd Company Detail
        11.9.2 Kyowa Hakko Kirin Co Ltd Business Overview
        11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.9.4 Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.9.5 Kyowa Hakko Kirin Co Ltd Recent Development
    11.10 Medifron DBT Co Ltd
        11.10.1 Medifron DBT Co Ltd Company Detail
        11.10.2 Medifron DBT Co Ltd Business Overview
        11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.10.4 Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.10.5 Medifron DBT Co Ltd Recent Development
    11.11 Neurim Pharmaceuticals Ltd
        11.11.1 Neurim Pharmaceuticals Ltd Company Detail
        11.11.2 Neurim Pharmaceuticals Ltd Business Overview
        11.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.11.4 Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.11.5 Neurim Pharmaceuticals Ltd Recent Development
    11.12 Pila Pharma AB
        11.12.1 Pila Pharma AB Company Detail
        11.12.2 Pila Pharma AB Business Overview
        11.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.12.4 Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.12.5 Pila Pharma AB Recent Development
    11.13 Sylentis SAU
        11.13.1 Sylentis SAU Company Detail
        11.13.2 Sylentis SAU Business Overview
        11.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.13.4 Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.13.5 Sylentis SAU Recent Development
    11.14 Toray Industries Inc
        11.14.1 Toray Industries Inc Company Detail
        11.14.2 Toray Industries Inc Business Overview
        11.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.14.4 Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.14.5 Toray Industries Inc Recent Development
    11.15 Vitality Biopharma Inc
        11.15.1 Vitality Biopharma Inc Company Detail
        11.15.2 Vitality Biopharma Inc Business Overview
        11.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
        11.15.4 Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
        11.15.5 Vitality Biopharma Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of CMX-020
    Table 3. Key Players of CA-016
    Table 4. Key Players of DD-04107
    Table 5. Key Players of Others
    Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2017-2022)
    Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2023-2028)
    Table 12. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
    Table 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
    Table 14. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
    Table 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
    Table 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players (2017-2022)
    Table 18. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2021)
    Table 19. Ranking of Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
    Table 23. Date of Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2017-2022)
    Table 27. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2023-2028)
    Table 29. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2017-2022)
    Table 31. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2023-2028)
    Table 33. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Inc Company Detail
    Table 44. Amgen Inc Business Overview
    Table 45. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 46. Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 47. Amgen Inc Recent Development
    Table 48. Amorepacific Corp Company Detail
    Table 49. Amorepacific Corp Business Overview
    Table 50. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 51. Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 52. Amorepacific Corp Recent Development
    Table 53. BCN Peptides SA Company Detail
    Table 54. BCN Peptides SA Business Overview
    Table 55. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 56. BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 57. BCN Peptides SA Recent Development
    Table 58. Centrexion Therapeutics Corp Company Detail
    Table 59. Centrexion Therapeutics Corp Business Overview
    Table 60. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 61. Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 62. Centrexion Therapeutics Corp Recent Development
    Table 63. Daewoong Pharmaceutical Co Ltd Company Detail
    Table 64. Daewoong Pharmaceutical Co Ltd Business Overview
    Table 65. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 66. Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 67. Daewoong Pharmaceutical Co Ltd Recent Development
    Table 68. DoNatur GmbH Company Detail
    Table 69. DoNatur GmbH Business Overview
    Table 70. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 71. DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 72. DoNatur GmbH Recent Development
    Table 73. Flex Pharma Inc Company Detail
    Table 74. Flex Pharma Inc Business Overview
    Table 75. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 76. Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 77. Flex Pharma Inc Recent Development
    Table 78. Grunenthal GmbH Company Detail
    Table 79. Grunenthal GmbH Business Overview
    Table 80. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 81. Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 82. Grunenthal GmbH Recent Development
    Table 83. Kyowa Hakko Kirin Co Ltd Company Detail
    Table 84. Kyowa Hakko Kirin Co Ltd Business Overview
    Table 85. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 86. Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 87. Kyowa Hakko Kirin Co Ltd Recent Development
    Table 88. Medifron DBT Co Ltd Company Detail
    Table 89. Medifron DBT Co Ltd Business Overview
    Table 90. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
    Table 91. Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 92. Medifron DBT Co Ltd Recent Development
    Table 93. Neurim Pharmaceuticals Ltd Company Detail
    Table 94. Neurim Pharmaceuticals Ltd Business Overview
    Table 95. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1Product
    Table 96. Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 97. Neurim Pharmaceuticals Ltd Recent Development
    Table 98. Pila Pharma AB Company Detail
    Table 99. Pila Pharma AB Business Overview
    Table 100. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1Product
    Table 101. Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 102. Pila Pharma AB Recent Development
    Table 103. Sylentis SAU Company Detail
    Table 104. Sylentis SAU Business Overview
    Table 105. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1Product
    Table 106. Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 107. Sylentis SAU Recent Development
    Table 108. Toray Industries Inc Company Detail
    Table 109. Toray Industries Inc Business Overview
    Table 110. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1Product
    Table 111. Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 112. Toray Industries Inc Recent Development
    Table 113. Vitality Biopharma Inc Company Detail
    Table 114. Vitality Biopharma Inc Business Overview
    Table 115. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1Product
    Table 116. Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022) & (US$ Million)
    Table 117. Vitality Biopharma Inc Recent Development
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2021 VS 2028
    Figure 2. CMX-020 Features
    Figure 3. CA-016 Features
    Figure 4. DD-04107 Features
    Figure 5. Others Features
    Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application in 2021 & 2028
    Figure 7. Ophthalmology Case Studies
    Figure 8. Immunology Case Studies
    Figure 9. Muscle Spasm Case Studies
    Figure 10. Pruritus Case Studies
    Figure 11. Abdominal Pain Case Studies
    Figure 12. Others Case Studies
    Figure 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 Report Years Considered
    Figure 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2021 VS 2028
    Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2021
    Figure 18. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2021
    Figure 20. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2017-2028)
    Figure 22. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2017-2028)
    Figure 26. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2017-2028)
    Figure 34. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2017-2028)
    Figure 42. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2017-2028)
    Figure 46. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Amgen Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 49. Amorepacific Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 50. BCN Peptides SA Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 51. Centrexion Therapeutics Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 52. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 53. DoNatur GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 54. Flex Pharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 55. Grunenthal GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 56. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 57. Medifron DBT Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 58. Neurim Pharmaceuticals Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 59. Pila Pharma AB Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 60. Sylentis SAU Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 61. Toray Industries Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 62. Vitality Biopharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc
Amorepacific Corp
BCN Peptides SA
Centrexion Therapeutics Corp
Daewoong Pharmaceutical Co Ltd
DoNatur GmbH
Flex Pharma Inc
Grunenthal GmbH
Kyowa Hakko Kirin Co Ltd
Medifron DBT Co Ltd
Neurim Pharmaceuticals Ltd
Pila Pharma AB
Sylentis SAU
Toray Industries Inc
Vitality Biopharma Inc
Frequently Asked Questions
Transient Receptor Potential Cation Channel Subfamily V Member 1 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transient Receptor Potential Cation Channel Subfamily V Member 1 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transient Receptor Potential Cation Channel Subfamily V Member 1 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Leiomyosarcoma Drug

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More